Boosting the HRQoL Among HIV+ Mothers and Children

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

February 28, 2025

Conditions
HIVPerinatal HIV Infection
Interventions
BEHAVIORAL

Resilience intervention

"Contents of the first session include:~1. Resilience. Know the concept of resilience.~2. Stigma management. Discuss stigma experience and learn stigma management strategies such as normalizing the disease.~3. Self-efficacy. Learn ways of improving self-efficacy, such as experience of success and social support.~Contents of the second session include:~1. Mother-child interaction skills. Identify speaking styles that have a negative influence on mother-child interactions. Learn effective communication skills.~2. Acquiring social support. Know people and resources that could provide support when having HIV-related difficulties and mental health problems.~3. Emotional regulation. Understand the physiological responses to emotions. Know a range of emotional regulation strategies, such as cognitive reappraisal and deep breathing."

BEHAVIORAL

Adherence intervention

"Contents of the first session include:~1. Adherence behavioral skills. Identify barriers to optimal HAART adherence. Know behavioral skills that can deal with these barriers, such as forgetting, afraid of others' questioning and side effects.~2. Adherence information and motivation. Know how the HIV virus attack human body and the mechanisms of HAART medication. Understand the influence of adherence level on health outcomes.~Contents of the second session include:~1. Adherence motivation. Discuss possibilities and hope of future life, intimate relationship and career.~2. Mother-child interaction skills. Identify speaking styles that have a negative influence on mother-child interactions concerning HAART medication. Learn effective communication skills.~3. Acquiring social support. Know people and resources that could provide support when having HAART-related difficulties and problems."

Trial Locations (1)

530027

RECRUITING

Guangxi Center for Disease Prevention and Control, Nanning

All Listed Sponsors
lead

City University of Hong Kong

OTHER